UK markets closed

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
18.15+0.35 (+1.97%)
As of 12:04PM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts111412
Avg. Estimate0.450.431.741.83
Low estimate0.450.431.471.55
High estimate0.450.431.861.99
Year ago EPS0.440.41.681.74
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts221312
Avg. Estimate7.7B8.32B34.96B37.11B
Low estimate7.35B8.32B34.45B35.69B
High estimate8.06B8.32B35.75B38.71B
Year ago sales11.44B8.1B35.26B34.96B
Sales growth (year/est)-32.60%2.60%-0.90%6.10%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS0.410.340.480.26
Actual EPS0.440.40.570.31
Difference0.030.060.090.05
Surprise %7.30%17.60%18.70%19.20%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate0.450.431.741.83
7 days ago0.460.441.761.9
30 days ago0.420.411.711.85
60 days ago0.420.411.761.88
90 days ago0.40.391.661.8
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 days112N/A
Up last 30 days1152
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A12
Growth estimatesGLAXFIndustrySector(s)S&P 500
Current qtr.2.30%N/AN/AN/A
Next qtr.7.50%N/AN/AN/A
Current year3.60%N/AN/AN/A
Next year5.20%N/AN/AN/A
Next 5 years (per annum)0.09%N/AN/AN/A
Past 5 years (per annum)-1.44%N/AN/AN/A